Sign in

CIK 0001971387 · <br>Emerging growth company

Liminatus Pharma, Inc.

Sign in to watch
Ticker
LIMN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
213-273-5453
Business address
12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
Former names
Iris Parent Holding Corp.

Securities

  • LIMN Class A Common Stock Nasdaq
  • LIMNW Warrants Nasdaq
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Other events
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Delisting notice
  5. 10-Q Report Quarterly Report
  6. 8-K/A Event Acquisition or sale completed
  7. NT 10-Q Other NT 10-Q
  8. SCHEDULE 13D Stake Beneficial Ownership Report
  9. SCHEDULE 13D Stake Beneficial Ownership Report
  10. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure · Other events
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 8-K12B Other 8-K12B
  20. 424B3 Offering Prospectus

Page 4 of 6 · 109 filings